Nancy Ham - Aug 15, 2023 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: Director
Signature: Nancy Ham
Stock symbol: USPH
Transactions as of: Aug 15, 2023
Transactions value $: -$25,394
Form type: 4
Date filed: 8/16/2023, 04:32 PM
Previous filing: May 26, 2023
Next filing: Mar 14, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common Stock	Sale	-$25.4K	-240	-15%	$105.81	1.36K	Aug 15, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $105.72 to $106.28, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2	Includes 1,200 shares of common stock that were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares on October 1, 2023, January 1, 2024 and April 1, 2024, if she is a director of the Company on those dates.

Content

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $105.72 to $106.28, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Includes 1,200 shares of common stock that were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares on October 1, 2023, January 1, 2024 and April 1, 2024, if she is a director of the Company on those dates.